Black Rock Inc. Rx Sight, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,109,559 shares of RXST stock, worth $123 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,109,559

Previous 2,076,470 1.59%

Holding current value

$123 Million

Previous $83.7 Million 29.97%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$35.51 - $57.92 $1.17 Million - $1.92 Million	33,089 Added 1.59%	2,109,559 $109 Million
Q4 2023 Feb 13, 2024	BUY	$20.91 - $40.9 $4.67 Million - $9.14 Million	223,381 Added 12.05%	2,076,470 $83.7 Million
Q3 2023 Nov 13, 2023	BUY	$27.05 - $33.37 $6.04 Million - $7.45 Million	223,161 Added 13.69%	1,853,089 $51.7 Million
Q2 2023 Aug 11, 2023	BUY	$16.37 - $28.9 $6.26 Million - $11 Million	382,119 Added 30.62%	1,629,928 $46.9 Million
Q1 2023 May 12, 2023	BUY	$12.58 - $16.68 $2.8 Million - $3.72 Million	222,907 Added 21.75%	1,247,809 $20.8 Million

Q4 2022 Feb 13, 2023	BUY	$9.93 - $14.2 $397,557 - $568,511	40,036 Added 4.07%	1,024,902 $13 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $473,627 - $670,867	42,326 Added 4.49%	984,866 $11.8 Million
Q2 2022 Aug 12, 2022	BUY	$10.61 - $16.66 $2.2 Million - $3.45 Million	206,951 Added 28.13%	942,540 $13.3 Million
Q1 2022 May 12, 2022	BUY	$8.97 - $14.03 $3.05 Million - $4.77 Million	340,091 Added 85.99%	735,589 $9.11 Million
Q4 2021 Feb 10, 2022	BUY	$9.52 - $13.81 $435,511 - $631,766	45,747 Added 13.08%	395,498 $4.45 Million
Q3 2021 Nov 09, 2021	BUY	$11.85 - $17.32 $4.14 Million - $6.06 Million	349,751 New	349,751 $4.43 Million

Others Institutions Holding RXST

# of Institutions

199

Shares Held

25.6M

Call Options Held

67K

Put Options Held

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.62B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account